Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies
Targeted drug delivery is one of the attractive ways in which cancer treatment can
significantly reduce side effects. In the last two decades, the use of antibodies as a tool for …
significantly reduce side effects. In the last two decades, the use of antibodies as a tool for …
A Nanorobotics-Based Approach of Breast Cancer in the Nanotechnology Era
We are living in an era of advanced nanoscience and nanotechnology. Numerous
nanomaterials, culminating in nanorobots, have demonstrated ingenious applications in …
nanomaterials, culminating in nanorobots, have demonstrated ingenious applications in …
Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging
F Mulero, M Oteo, G Garaulet, N Magro… - Frontiers in …, 2022 - frontiersin.org
Triple-negative breast cancer (TNBC) is characterized by aggressiveness and high rates of
metastasis. The identification of relevant biomarkers is crucial to improve outcomes for …
metastasis. The identification of relevant biomarkers is crucial to improve outcomes for …
Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and …
Z Zhu, H Wang, X Qian, M Xue, A Sun, Y Yin, J Tang… - Clinical breast …, 2024 - Elsevier
Background Cinobufagin (CBG), a key bioactive component in cinobufacini, exhibits
antitumor properties. This study explores CBG's impact on triple-negative breast cancer …
antitumor properties. This study explores CBG's impact on triple-negative breast cancer …
Nanobodies for the early detection of ovarian cancer
LH Tran, GJ Graulus, C Vincke, N Smiejkowska… - International journal of …, 2022 - mdpi.com
Ovarian cancer ranks fifth in cancer-related deaths among women. Since ovarian cancer
patients are often asymptomatic, most patients are diagnosed only at an advanced stage of …
patients are often asymptomatic, most patients are diagnosed only at an advanced stage of …
Development of a bioluminescent homogenous nanobody-based immunoassay for the detection of prostate-specific antigen (PSA)
ME Baghdadi, R Emamzadeh, M Nazari… - Enzyme and Microbial …, 2024 - Elsevier
Prostate cancer is the most prevalent cancer in men. At present, the diagnosis and
screening of prostate cancer rely on the essential biomarker known as prostate-specific …
screening of prostate cancer rely on the essential biomarker known as prostate-specific …
[HTML][HTML] Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer
JY Chen, JD Li, RQ He, ZG Huang… - World Journal of …, 2024 - ncbi.nlm.nih.gov
BACKGROUND Phosphoglycerate kinase 1 (PGK1) has been identified as a possible
biomarker for breast cancer (BC) and may play a role in the development and advancement …
biomarker for breast cancer (BC) and may play a role in the development and advancement …
Nanobody engineering: computational modelling and design for biomedical and therapeutic applications
Nanobodies, the smallest functional antibody fragment derived from camelid heavy‐chain‐
only antibodies, have emerged as powerful tools for diverse biomedical applications. In this …
only antibodies, have emerged as powerful tools for diverse biomedical applications. In this …
Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma: Relationship with prognostic factors and response to neoadjuvant chemotherapy
ÖA Solmaz, N Kutluer, MB Bozan - 2024 - researchsquare.com
Purpose Triple negative breast carcinoma is characterized by the absence of estrogen
receptor, progesterone receptor and HER2/neu receptor. Carbonic anhydrase IX (CA IX) is a …
receptor, progesterone receptor and HER2/neu receptor. Carbonic anhydrase IX (CA IX) is a …